google.com, pub-8701563775261122, DIRECT, f08c47fec0942fa0
USA

Strong International Growth and …

This article was first published on: GuruFocus.

  • Revenues: $10.4 billion in the third quarter, with a 4% annual increase and 5% organic growth.

  • Segment Operating Margin: It increased by 80 basis points to 12.3% in the third quarter.

  • Earnings Per Share (EPS): $7.67, up 10% from the previous year.

  • Free Cash Flow: It increased by 72% in the third quarter compared to the previous year.

  • Book-to-Invoice Ratio: 1.17 for the quarter.

  • Organic Growth Rate: 5% per annum.

  • International Growth Rate: 32% on an annual basis.

  • Aviation Sales: $3.1 billion, up 6% from the previous year.

  • Defense Systems Sales: Approximately $2.1 billion, up 14% from the previous year, with 19% organic growth.

  • Mission Systems Sales Increase: Double-digit growth driven by microelectronics programs.

  • Space Systems Sales: $2.7 billion, sequential growth, mid-single digit decline year over year.

  • Operating Income Increase: 11% year-on-year in the third quarter.

  • 2025 Income Guide: It was revised from $41.7 billion to $41.9 billion.

  • 2026 Free Cash Flow Outlook: From $3.1 billion to $3.5 billion.

Release Date: October 21, 2025

For the full earnings call, please see: full earnings call transcript.

  • Northrop Grumman Corp (NYSE:NOC) achieved mid-single-digit growth and expanded segment operating margin in the third quarter of 2025.

  • The company reported a strong book-to-bill ratio of 1.17, indicating strong demand for its products and services.

  • International growth was particularly strong, with a 32% year-over-year increase, contributing to a 20% year-to-date growth in international sales.

  • The B-21 program has made significant progress, with the second aircraft entering flight testing and negotiations to increase production rates beginning.

  • Northrop Grumman Corp (NYSE:NOC) increased its free cash flow by 72% over last year, in line with its long-term financial outlook.

  • The company revised its full-year revenue forecast downward due to delayed timing of certain awards and programs.

  • The space segment has faced challenges in revenue growth due to the termination of two major programs.

  • There were higher-than-expected costs in the production of the EMD flight test aircraft for the B-21 program.

  • The U.S. government shutdown created potential risks that could lead to further delays in program awards and funding.

  • Supply chain concerns remain, particularly regarding rare earth elements, which could impact future operations.

Q: Can you say more about the potential impact of F/A-XX and B-21 acceleration on your 2026 outlook? A.: CEO Kathy Warden clarified that neither F/A-XX nor B-21 acceleration is included in the 2026 outlook. Acquiring F/A-XX will increase revenue but may dilute earnings due to its developmental nature. The B-21 launcher would also increase sales but would require investment with long-term return potential. The guidance will be updated if clarity on these opportunities is provided.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button